GlassScriptPhysician profile
Amanda West Pybus
NPI 1164869954
$12,915.81
in general payments reported to CMS, 2019-2025
34 companies · $3,275 in 2025
The $3,275 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,612 · 2022: $2,815 · 2023: $2,527 · 2024: $2,687 · 2025: $3,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,395 · Education: $94.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,394.50 |
| Education | $94.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,489.16 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,167.38 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,063.29 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Takeda Pharmaceuticals U.S.A., INC. | $755.28 | 2021-2025 | Glassia, Cuvitru, Hyqvia |
| Regeneron Healthcare Solutions, INC. | $754.00 | 2021-2025 | Dupixent |
| Amgen INC. | $665.98 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $527.78 | 2021-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $500.81 | 2021-2025 | |
| Mylan Specialty L.P. | $416.43 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $414.91 | 2021-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $337.22 | 2022-2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $276.37 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $203.82 | 2021-2025 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $164.03 | 2023-2025 | Sunosi |
| Electromed, INC. | $156.27 | 2023-2025 | Smartvest |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $146.27 | 2025 | Ohtuvayre |
| Gilead Sciences, INC. | $140.33 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $108.54 | 2021-2024 | Keytruda, Belsomra |
| Sanofi-Aventis U.S. LLC | $94.95 | 2024 | |
| Harmony Biosciences LLC | $57.62 | 2025 | |
| 3b Medical, INC. | $57.01 | 2024-2025 | Luna |
| Ethicon INC. | $50.88 | 2022-2023 | Monarch Platform |
| Philips North America LLC | $45.41 | 2023 | |
| Fisher & Paykel Healthcare INC | $43.24 | 2022 | |
| Inogen, INC. | $42.42 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Vifor Pharma, INC. | $41.57 | 2024-2025 | Zemaira |
| Viatris Specialty LLC | $40.00 | 2025 | Yupelri |
| Abbvie INC. | $35.01 | 2021-2022 | |
| Tactile Systems Technology INC | $34.10 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Genentech USA, INC. | $20.97 | 2025 | Xolair |
| Alexion Pharmaceuticals, INC. | $18.21 | 2022 | |
| Advanced Respiratory, INC | $17.59 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.94 | 2021 | |
| Baxter Healthcare | $14.02 | 2024 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Pybus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.